Skip to main content
Caplight Logo









PrecisioBiotix Therapeutics

PrecisioBiotix Therapeutics

Private
Dover, DelawareHealthcare & Life Scienceshttps://www.precisiobiotix.com/

Last Round

Grant

Jun 16, 2025

Total Funding Raised

$1.48M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

PrecisioBiotix Therapeutics is a biotechnology company that develops precision antibacterial biological solutions, including lysin, phage, and amurin products, to combat antibiotic-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Infrastructure

Keywords

biotechnologydrug discoveryantimicrobial resistancephage therapylysinAMRAI drug discoveryprecision medicineantibacterialbioinformaticsbiologicsdrug developmentbio-pharmacosmeceuticalstopical therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PrecisioBiotix Therapeutics Comparables

Compare PrecisioBiotix Therapeutics with similar companies based on industry and business-model similarity.

PrecisioBiotix Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Locus Biosciences
82%
Micreos
82%
BioNTech SE
78%

PrecisioBiotix Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 16, 2025

PrecisioBiotix Therapeutics Investors

Notable investors and investment history

PrecisioBiotix Therapeutics investors
InvestorRounds
Bill & Melinda Gates FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Grew 38% QoQ, from 8 to 11 employees.

  • Jan 28, 2026

    Monthly visitors increased 39% MoM, reaching 1K.

PrecisioBiotix Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PrecisioBiotix Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PrecisioBiotix Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDover, Delaware
Employee Range11
Year Founded2013
Last FundingJun 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?